期刊文献+

硝苯地平控释片和雷米普利降血压作用及对肾功能的影响

The effect of nifedipine and ramipril of lowering blood pressure and the impact on renal function
下载PDF
导出
摘要 目的观察并比较硝苯地平控释片和雷米普利对慢性肾脏病(CKD)患者的降压效果以及对肾功能的影响。方法将46例CKD患者随机分为两组,雷米普利(2.5mg/d)组与硝苯地平(30mg/d)组,每组23例,连续使用8周,比较两组治疗前后24h平均收缩压(SBP)和平均舒张压(DBP),昼、夜间SBP和DBP,24h尿蛋白定量及肾功能的变化。结果两组患者的SBP和DBP均有所下降。降压的同时,雷米普利组82%的患者、硝苯地平组78%的患者恢复了血压的昼夜节律,血肌酐、尿蛋白有所下降。雷米普利组24h尿蛋白定量减少幅度明显高于硝苯地平组。结论硝苯地平和雷米普利对CKD患者均有良好的降压效果和改善肾功能的作用,雷米普利降低尿蛋白的疗效明显强于硝苯地平。 Objective To investigate and compare the effect of nifedipine and ramipril of lower ing blood pressure of patients with chronic kidney disease(CKD) and the impact on renal function. Methods Forty-six patients with CKD were equally and randomly divided into two groups,receiving 2. 5 mg ramipril and 30 mg nifedipine once daily for 8 weeks. Changes of 24 h systolic blood pressure (SBP) and diastolic blood pressure(DBP), day SBP and DBP, night SBP and DBP, the renal function and urine protein were detected before and after the treatment. Results Twenty-four systolic blood pressure and diastolic blood pressure were significantly decreased in both two groups. 82% of the patients in rmnipril group and 78% of the patients in nifedipine group recovered their day and night rhythm of blood pressure. The blood creatinine and urine pratein were decreased signifieantly. In ranlipril group, the excretion of urine protein was significantly lower than that in the nifedipine group. Conclusions Nifedipine and ramipril can significantly lower blood pressure and protect renal function of the patient with CKD, and the efficacy of ramipril reducing urine protein level was more significant than nifedipine.
出处 《临床肾脏病杂志》 2009年第12期549-552,共4页 Journal Of Clinical Nephrology
关键词 硝苯地平 雷米普利 治疗 血压 Nifedipine Ramipril Therapy Blood pressure
  • 相关文献

参考文献8

二级参考文献89

  • 1蒋建平,侯凡凡,高丽真,潘阳彬,杨念生,陈葳,舒贵扬,陈友明,陈建,彭卫华,吴建平,杨忠民.早期纠正贫血对慢性肾衰竭心血管病变影响的多中心临床研究[J].中华内科杂志,2005,40(1):25-29. 被引量:11
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 3马中,陈威,韩增辉,刘洪宝,孙世仁,王汉民.血透患者动静脉内瘘直径对心脏功能影响的相关性研究[J].心脏杂志,2006,18(6):699-701. 被引量:14
  • 4[1]Chobanian AV, Bakris GL, Black HR, et al.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation,and Treatment of High Blood Pressure: the JNC 7 report [J ] .JAMA,2003,289(20) :2560 ~ 72.
  • 5[2]Kidney Disease Outcomes Quality Initiative ( K/DOQI ) .K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease[J] .Am J Kidney Dis, 2004, 43(Suppl 1 ) :S1 ~ 290.
  • 6[3]Flack JM, Peters R, Shafi T, et al.Prevention of hypertension and its complications: theoretical basis and guidelines for treatment [J]. J Am Soc Nephrol,2003,14(Suppl 2):S92~8.
  • 7[5]Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men 16 year MRFIT findings [J] .JAMA,1997, 277(16): 1293 ~ 8.
  • 8[6]Bakris GL, Weir MR, Shanifar S, et al. Effects of blood pressure level on progression of diabetic nephropathy: Results from the RENAAL study [ J ]. Arch Intern Med, 2003, 63 (12): 1555 ~ 65.
  • 9[7]Burt VL, Cutler JA, Higgins M, et al.Trends in the prevalence,awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991[J]. Hypertension, 1995, 26( 1 ) :60 ~ 9.
  • 10[8]Levin A, Singer J, Thompson CR, et al.Prevalent left ventricular hypertrophy in the predialysis population:identifying opportunities for intervention[J] .Am J Kidney Dis, 1996, 27(2) :347 ~ 54.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部